Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. (Q39135834)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 July 2013

Language	Label	Description	Also known as
English	Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.	scientific article published on 19 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

0 references

cannabinoid receptor

0 references

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Stefanie D Krämer

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Simon M Ametamey

10

object named as

Simon M Ametamey

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3

object named as

Roger Slavik

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Adrienne Müller Herde

5

object named as

Adrienne Müller

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

6

object named as

Stjepko Cermak

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

object named as

Daniel Bieri

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Konstantin Drandarov

4

object named as

Konstantin Drandarov

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Markus Weber

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

0 references

publication date

19 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

126

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

616-624

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23795580%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepo

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

The endocannabinoid system and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid receptors: nomenclature and pharmacological principles

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Radiosynthesis of novel carbon-11-labeled triaryl ligands for cannabinoid-type 2 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

P-Glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2).

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Positron emission tomography imaging in multiple sclerosis-current status and future applications

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid receptors and their endogenous ligands

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

An admonition when measuring the lipophilicity of radiotracers using counting techniques

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12354

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39135834&oldid=1773569860"